These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29797376)

  • 1. Linaclotide inhibits colonic and urinary bladder hypersensitivity in adult female rats following unpredictable neonatal stress.
    Ligon C; Mohammadi E; Ge P; Hannig G; Higgins C; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2018 Oct; 30(10):e13375. PubMed ID: 29797376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linaclotide Attenuates Visceral Organ Crosstalk: Role of Guanylate Cyclase-C Activation in Reversing Bladder-Colon Cross-Sensitization.
    Mohammadi EN; Ligon CO; Silos-Santiago A; Ge P; Kurtz C; Higgins C; Hannig G; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2018 Aug; 366(2):274-281. PubMed ID: 29784661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral Guanylate Cyclase-C modulation of corticolimbic activation and corticotropin-releasing factor signaling in a rat model of stress-induced colonic hypersensitivity.
    Ligon CO; Hannig G; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2021 Mar; 33(3):e14076. PubMed ID: 33373484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
    Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
    Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
    Eutamene H; Bradesi S; Larauche M; Theodorou V; Beaufrand C; Ohning G; Fioramonti J; Cohen M; Bryant AP; Kurtz C; Currie MG; Mayer EA; Bueno L
    Neurogastroenterol Motil; 2010 Mar; 22(3):312-e84. PubMed ID: 19706070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological and clinical profile of linaclotide (Linzess
    Keto Y; Kosako M
    Nihon Yakurigaku Zasshi; 2019; 153(6):289-298. PubMed ID: 31178535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction.
    Grundy L; Harrington AM; Castro J; Garcia-Caraballo S; Deiteren A; Maddern J; Rychkov GY; Ge P; Peters S; Feil R; Miller P; Ghetti A; Hannig G; Kurtz CB; Silos-Santiago I; Brierley SM
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive Effects of an Anti-CGRP Antibody in Rat Models of Colon-Bladder Cross-Organ Sensitization.
    Noor-Mohammadi E; Ligon CO; Mackenzie KD; Stratton J; Shnider SJ; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2023 Oct; 387(1):4-14. PubMed ID: 37164371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
    Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
    J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linaclotide activates guanylate cyclase-C/cGMP/protein kinase-II-dependent trafficking of CFTR in the intestine.
    Ahsan MK; Tchernychev B; Kessler MM; Solinga RM; Arthur D; Linde CI; Silos-Santiago I; Hannig G; Ameen NA
    Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28592587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linaclotide increases cecal pH, accelerates colonic transit, and increases colonic motility in irritable bowel syndrome with constipation.
    Farmer AD; Ruffle JK; Hobson AR
    Neurogastroenterol Motil; 2019 Feb; 31(2):e13492. PubMed ID: 30353623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Monoclonal Anti-Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity.
    Noor-Mohammadi E; Ligon CO; Mackenzie K; Stratton J; Shnider S; Greenwood-Van Meerveld B
    J Pharmacol Exp Ther; 2021 Nov; 379(3):270-279. PubMed ID: 34620725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tadalafil versus linaclotide in gastrointestinal dysfunction and depressive behavior in constipation-predominant irritable bowel syndrome.
    Sedky AA; Magdy Y
    Life Sci; 2020 Sep; 256():117960. PubMed ID: 32534033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related differences in pain behaviors following three early life stress paradigms.
    Prusator DK; Greenwood-Van Meerveld B
    Biol Sex Differ; 2016; 7():29. PubMed ID: 27293543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study.
    Fukudo S; Nakajima A; Fujiyama Y; Kosako M; Nakagawa A; Akiho H; Nakashima Y; Johnston JM; Miwa H
    Neurogastroenterol Motil; 2018 May; 30(5):e13275. PubMed ID: 29278278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic mechanisms underlying stress-induced visceral pain: Resilience versus vulnerability in a two-hit model of early life stress and chronic adult stress.
    Louwies T; Mohammadi E; Greenwood-Van Meerveld B
    Neurogastroenterol Motil; 2023 May; 35(5):e14558. PubMed ID: 36893055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRP4 Modulation of the Guanylate Cyclase-C/cGMP Pathway: Effects on Linaclotide-Induced Electrolyte Secretion and cGMP Efflux.
    Tchernychev B; Ge P; Kessler MM; Solinga RM; Wachtel D; Tobin JV; Thomas SR; Lunte CE; Fretzen A; Hannig G; Bryant AP; Kurtz CB; Currie MG; Silos-Santiago I
    J Pharmacol Exp Ther; 2015 Oct; 355(1):48-56. PubMed ID: 26216942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Linaclotide in Children with Functional Constipation or Irritable Bowel Syndrome: A Retrospective Chart Review.
    Baaleman DF; Gupta S; Benninga MA; Bali N; Vaz KH; Yacob D; Di Lorenzo C; Lu PL
    Paediatr Drugs; 2021 May; 23(3):307-314. PubMed ID: 33876403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.
    Rao SS; Quigley EM; Shiff SJ; Lavins BJ; Kurtz CB; MacDougall JE; Currie MG; Johnston JM
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.